Cargando…

Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study

BACKGROUND: As the COVID-19 pandemic continues to spread, the number of associated deaths continues to increase, especially among those with pre-existing conditions. Azvudine is recommended as a priority treatment for patients with COVID-19, but its efficacy in patients with pre-existing conditions...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yuming, Jin, Liping, Dian, Yating, Shen, Minxue, Zeng, Furong, Chen, Xiang, Deng, Guangtong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167478/
https://www.ncbi.nlm.nih.gov/pubmed/37193346
http://dx.doi.org/10.1016/j.eclinm.2023.101981